Key result
Patient-triggered events on 14-day post-TAVI ECG patches had no arrhythmia in 44% of cases and missed 100% of high-grade AV blocks and VTs.
Why the study?
Do patient-triggered symptom events during 14-day continuous ECG patch monitoring reliably identify clinically relevant arrhythmias in adult patients after TAVI?
Cohort (n=315)
No
Do patient-triggered symptom events during 14-day continuous ECG patch monitoring reliably identify clinically relevant arrhythmias in adult patients after TAVI?
Patient-reported symptom triggers during wearable ECG patch monitoring after TAVI fail to capture critical arrhythmias such as high-grade AV block, pauses, and most atrial fibrillation episodes, underscoring the necessity of systematic continuous rhythm surveillance.
Answers are grounded in this paper and cite their sources.
Symptom-driven surveillance may miss post-TAVI arrhythmias; leaves open whether routine continuous ECG improves outcomes.
BACKGROUND: Wearable ECG patches after transcatheter aortic valve implantation (TAVI) enable continuous rhythm monitoring and allow symptoms reporting via trigger buttons and diary entries. However, the reliability of triggered events to identify clinically relevant arrhythmias after TAVI is uncertain. OBJECTIVES: We systematically analyzed patient-triggered events and their corresponding rhythm findings during 14-day ECG patch monitoring after TAVI. METHODS: Adult patients undergoing TAVI at a Swiss tertiary centre were prospectively enrolled and monitored with a 14-day ECG patch before discharge. Patients recorded any cardiac-related symptoms using the patch trigger button and/or diary function. RESULTS: Among 315 patients (median age 82 years [78-87], 43% female), median analyzable duration was 14 days [13-14]. At least one patient-triggered event was recorded in 94 patients (30%), with a median of 2 events per patient [1-4]. Atrial fibrillation (AF) was detected in 85 patients (27%), including 17 patients (5.4%) with new AF; however, only 20 patients with AF (24%) reported symptoms during AF episodes. Pauses occurred in 58 patients (18%) and high-grade atrioventricular block in 32 patients (10%), with no associated patient-triggered events. Ventricular tachycardia (≥4 beats) occurred in 165 patients (52%) and was entirely asymptomatic. Of 348 evaluable symptom-triggered events, 153 (44%) occurred without associated arrhythmia. The most frequent arrhythmias associated with symptom-triggered events were premature atrial contractions (21%), AF (14%), and premature ventricular contractions (11%). CONCLUSIONS: After TAVI, patient-triggered events during ECG patch monitoring poorly reflect objectively documented arrhythmias and fail to identify many clinically relevant rhythm disturbances. These findings support systematic continuous ECG surveillance beyond symptom-driven monitoring strategies after TAVI.
No takes yet. Share an insight, caveat, or question.
Bettelini et al. (2026) conducted a cohort in Transcatheter aortic valve implantation (TAVI) (n=315). 14-day wearable ECG patch monitoring with patient-triggered symptom reporting was evaluated on Patient-triggered symptom events and corresponding rhythm findings (arrhythmias). Patient-triggered events on 14-day post-TAVI ECG patches had no arrhythmia in 44% of cases and missed 100% of high-grade AV blocks and VTs.
Synapse has enriched 10 related papers. Consider them for comparative context: